MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients Meeting Abstract

  

Authors:	Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; Weisdorf, D. J.; Zhang, Y.; Tallman, M.; Saber, W.
Abstract Title:	MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients
Meeting Title:	Biology of Blood and Marrow TransTransplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	26
Issue:	3 Suppl.
Meeting Dates:	2020 Feb 19-23
Meeting Location:	Orlando, FL
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2020-03-01
Start Page:	S10
End Page:	S11
Language:	English
ACCESSION:	WOS:000516887900011
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2019.12.074
Notes:	Meeting Abstract: 10 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/164025